Narrow search
Showing 1 - 10 of 205
Cover Image
A Structural Approach to Market Definition With an Application to the Hospital Industry
Gaynor, Martin - 2011
Market definition is essential to merger analysis. Because no standard approach to market definition exists, opposing parties in antitrust cases often disagree about the extent of the market. These differences have been particularly relevant in the hospital industry, where the courts have denied...
Persistent link: https://www.econbiz.de/10012462001
Cover Image
Some Economic Aspects of Antitrust Analysis in Dynamically Competitive Industries
Evans, David S. - 2001
Competition in many important industries centers on investment in intellectual property. Firms engage in dynamic, Schumpeterian competition for the market, through sequential winner-take-all races to produce drastic innovations, rather than through static price/output competition in the market....
Persistent link: https://www.econbiz.de/10012470456
Cover Image
Business environment and firm entry : evidence from international data
Klapper, Leora - 2004
"Using a comprehensive database of firms in Western and Eastern Europe, we study how the business environment in a country drives the creation of new firms. Our focus is on regulations governing entry. We find entry regulations hamper entry, especially in industries that naturally should have...
Persistent link: https://www.econbiz.de/10010523101
Cover Image
If at First You Don't Succeed... : Profits, Prices and Market Structure in a Model of Quality with Unknowable Consumer Heterogeneity
Krishna, Kala - 2000
Why are higher quality niches seen as intrinsically more profitable in business circles? Why do high quality products sometimes have a low real price, while it is unusual to see low quality products with high real prices? Can markets have quality differentiation as well as quality bunching? In...
Persistent link: https://www.econbiz.de/10012471282
Cover Image
Local Academic Science Driving Organizational Change : The Adoption of Biotechnology by Japanese Firms
Darby, Michael R. - 1999
The local academic science base plays a dominant role in determining where and when biotechnology is adopted by existing firms or -- much more frequently -- exploited by new entrants in the U.S. In Japan this new dominant technology has almost exclusively been introduced through organizational...
Persistent link: https://www.econbiz.de/10012471542
Cover Image
Mergers, Station Entry, and Programming Variety in Radio Broadcasting
Berry, Steven T. - 1999
products, concentration can affect incentives to enter as well as how to position products. This paper examines how product … effect of concentration on other factors such as the number of products and the extent of product variety, the 1996 … data set on 243 U.S. radio broadcast markets in 1993 and 1997, we find that concentration reduces entry and increases …
Persistent link: https://www.econbiz.de/10012471716
Cover Image
Most-Favored Entry Clauses in Drug Patent Litigation Settlements as a Potential Reverse Payment
Drake, Keith M.; McGuire, Thomas G. - National Bureau of Economic Research - 2022
Settlements of drug patent disputes that involve a potential payment from the brand to the generic signal a possible collusive profit split with a threat to competition, and have undergone intensive scrutiny in the literature on law and economics. A common feature of these brand-generic...
Persistent link: https://www.econbiz.de/10012938770
Cover Image
Preemptive Entry and Technology Diffusion : The Market for Drive-in Theaters
Gil, Ricard; Houde, Jean-François; Sun, Shilong; … - National Bureau of Economic Research - 2021
This paper studies the role and incidence of entry preemption strategic motives on the dynamics of new industries, while providing an empirical test for entry preemption, and quantifying its impact on market structure. The empirical context is the evolution of the U.S. drive-in theater market...
Persistent link: https://www.econbiz.de/10012660086
Cover Image
No Free Launch : At-Risk Entry by Generic Drug Firms
Drake, Keith M.; He, Robert; McGuire, Thomas G.; … - National Bureau of Economic Research - 2021
After receiving FDA approval, a generic drug manufacturer can launch "at risk" before conclusion of any patent infringement litigation, but it risks paying damages if it loses. The generic can eliminate the risk by waiting to launch until the appeals process is complete but waiting has downsides...
Persistent link: https://www.econbiz.de/10012616579
Cover Image
Entry and Exit of Informal Firms and Development
McCaig, Brian; Pavcnik, Nina - National Bureau of Economic Research - 2021
Non-farm informal businesses comprise the majority of the firm distribution in developing countries. We document novel stylized facts about entry and exit of informal, non-farm firms using nationally representative panel data over 15 years and across regions with varying levels of local economic...
Persistent link: https://www.econbiz.de/10012599276